Digestive & Intestinal Remedies (Pharmacies) - Japan

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$770.80m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.40%, resulting in a market volume of US$867.70m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$6.29 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Japan has been experiencing steady growth in recent years.

Customer preferences: Japanese consumers have shown a growing interest in digestive and intestinal remedies due to various factors. One major factor is the increasing awareness of digestive health and the importance of maintaining a healthy gut. Consumers are becoming more proactive in taking care of their digestive system and are seeking remedies that can help alleviate common digestive issues such as indigestion, bloating, and constipation. Additionally, the aging population in Japan has also contributed to the demand for digestive and intestinal remedies, as older adults are more prone to digestive health problems.

Trends in the market: One noticeable trend in the Digestive & Intestinal Remedies market in Japan is the rising popularity of natural and herbal remedies. Consumers are becoming more conscious about the ingredients they consume and are opting for products that are perceived to be more natural and gentle on the digestive system. This has led to an increase in the demand for products containing natural ingredients such as ginger, peppermint, and probiotics. Another trend in the market is the growing availability of over-the-counter (OTC) digestive and intestinal remedies. Previously, many of these products required a prescription from a doctor, but now they can be easily purchased at pharmacies without the need for a doctor's visit. This convenience has made these remedies more accessible to consumers and has contributed to the growth of the market.

Local special circumstances: Japan has a unique food culture that heavily emphasizes traditional and fermented foods such as miso, natto, and pickles. These foods are known for their probiotic properties and are believed to promote good digestive health. The popularity of these traditional foods has likely influenced the demand for digestive and intestinal remedies in Japan, as consumers seek to maintain a healthy gut despite changes in their diet and lifestyle.

Underlying macroeconomic factors: Japan has been facing an aging population and a declining birth rate, which has significant implications for the healthcare industry. With an increasing number of elderly individuals, the demand for healthcare services and products, including digestive and intestinal remedies, is expected to rise. Additionally, the government's focus on promoting preventive healthcare and wellness initiatives also supports the growth of the Digestive & Intestinal Remedies market in Japan. In conclusion, the Digestive & Intestinal Remedies market in Japan is growing due to customer preferences for natural remedies, the availability of OTC products, the influence of the local food culture, and underlying macroeconomic factors such as an aging population and government initiatives. This market is expected to continue its upward trajectory as consumers prioritize their digestive health and seek accessible and effective remedies.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.